We are live on ! Find out more
ACP

Acuta Capital Partners Portfolio holdings

AUM $142M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
+3.95%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$269M
AUM Growth
+$2.58M
Cap. Flow
-$7.75M
Cap. Flow %
-2.88%
Top 10 Hldgs %
61.2%
Holding
83
New
15
Increased
18
Reduced
11
Closed
33

Top Buys

Rank Stock Value
1
ACRS icon
Aclaris Therapeutics
ACRS
+$9.5M
2
ASMB icon
Assembly Biosciences
ASMB
+$8.21M
3
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
+$5.14M
4
IRIX icon
IRIDEX
IRIX
+$4.74M
5
ASND icon
Ascendis Pharma A/S
ASND
+$4.24M

Top Sells

Rank Stock Value
1
EVDY
Everyday Health, Inc.
EVDY
+$11.9M
2
AERI
Aerie Pharmaceuticals
AERI
+$8.7M
3
CEMP
Cempra, Inc.
CEMP
+$5.08M
4
INNL
Innocoll Holdings plc Ordinary Shares
INNL
+$3.9M
5
FOLD
Amicus Therapeutics
FOLD
+$3.63M

Sector Composition

Rank Sector Weight
1 Healthcare 77.17%
2 Technology 2.58%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALR
76
DELISTED
Alere Inc
ALR
– –
-45,000
Closed -$1.95M
INNL
77
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
– –
-671,517
Closed -$3.9M
EVDY
78
DELISTED
Everyday Health, Inc.
EVDY
– –
-1,550,000
Closed -$11.9M
PTX
79
PUT
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
– –
-7,350
Closed -$46K
CBMX
80
DELISTED
CombiMatrix Corporation
CBMX
– –
-47,431
Closed -$133K
SVA
81
DELISTED
Sinovac Biotech, Ltd
SVA
– –
-204,358
Closed -$1.21M
1 2 3
4

Similar funds

EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
HA
HFG Advisors Cincinatti, Ohio $142M AUM 16.9% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCAM
Kagan Cocozza Asset Management Mickleton, New Jersey $142M AUM 12.02% 1-Year Est. Return

Acuta Capital Partners's Q4 2016 Portfolio in Review

As of Q4 2016, Acuta Capital Partners held 83 positions worth $269M, up 0.97% from $266M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Acuta Capital Partners's Q4 2016 filing shows 15 new, 18 increased, 11 reduced and 33 closed positions. Its largest new stake was Aclaris Therapeutics: 372,753 shares worth $10.1M. The largest sale was Everyday Health, Inc., an estimated $11.9M.

By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 68% a quarter earlier, followed by Technology and Industrials.

  • Acuta Capital Partners's largest Q4 2016 buy was Aclaris Therapeutics: 372,753 shares worth $10.1M.
  • Acuta Capital Partners added most to Assembly Biosciences in Q4 2016, an estimated $8.21M increase.
  • Acuta Capital Partners's biggest Q4 2016 reduction was Aerie Pharmaceuticals, cutting an estimated $8.7M.
  • Acuta Capital Partners fully exited Everyday Health, Inc. in Q4 2016, selling an estimated $11.9M.
  • Acuta Capital Partners's ten largest holdings make up 61% of its $269M portfolio in Q4 2016.
  • Acuta Capital Partners opened 15 new positions and closed 33 in Q4 2016.
  • Acuta Capital Partners's portfolio value rose 0.97% quarter-over-quarter to $269M.

Based on Acuta Capital Partners's 13F filing for Q4 2016, filed 13 Feb 2017.